Home

Review Our Clinical White Papers to See How We Deal with Study Challenges

Every data management white paper we write is aimed toward helping you see how we’ve handled common challenges within the clinical research space. Because our study delivery team boasts a wide range of backgrounds and abilities, we’re uniquely positioned to address a broad spectrum of issues. Turning those pearls of wisdom into easy-to-read clinical white papers is a bigger challenge—but one we’re up to as well.

If you’d like to learn more about an approach you’ve learned about in our data management white paper—or if you have an issue that we haven’t covered—please contact us today. Be sure to check out our case studies for some real-world examples as well.

Embracing Adaptive Trials Can Help Alleviate Costs and Speed Needed Drugs to Market

Economic concerns, layoffs, trial delays, study cancellations, regulatory costs, inability to get needed drugs to market … as a result of a host of combined factors, the clinical research industry has reached a critical crossroads. Contract research organizations (CROs), biotechnology companies, pharmaceutical organizations and medical device companies are struggling to construct smooth pipelines in a space that seemingly grows more crowded and competitive with each passing day.

DIA Metrics Session Provides Guidance for Sponsors and Vendors: A report on a key industry topic from the 2009 DIA Annual Meeting

Metrics was a topic on many attendees’ mind at the 2009 DIA meeting in San Diego. Sponsor organizations, CROs and EDC companies alike have recognized the need for metrics to help differentiate and to accurately measure their performance. Over the last few years, companies have worked together through an industry consortium to draft a set of consistent metrics to evaluate the relationship between sponsors and outsourced service providers.